Delivery Order SPE2DB22D2206-SPE2DB25FJY55
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for EMERPHED 50 mg/10 mL vials with a ceiling value of $1,390.95 and a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order, with ultimate completion scheduled for August 11, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Emperphed 50 mg/10 ml vials with a ceiling value of $9,473.65. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Emperphed 50 mg/10 mL vials totaling $1,832.69. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $1,312.12 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,667,406 units of a EMERPHED 50 MG/10 ML SYRINGE 10ML pharmaceutical product. The order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, which has a potential value of $999,999,999.00 and runs through December 2025. This IDC serves as Amerisourcebergen's primary contract vehicle...
- The Defense Logistics Agency awarded a $1,436 delivery order to Amerisourcebergen Drug Corporation for 50 mg/10 ml vials of EMERPHED. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the drug to a location in Conshohocken, Pennsylvania under a firm fixed price contract starting August 4, 2023 and concluding on August 7, 2023. The parent company of Amerisourcebergen Drug Corporation is Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated....
- The Defense Logistics Agency awarded a $2,168.54 delivery order to AmerisourceBergen Drug Corp for EMERPHED 25 MG/5 ML syringes (5 ML) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- This is a $1,390.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product, with a period of performance through March 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,225.52 delivery order to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Emperfed 50 mg/10 mL vials. The contract, which is a child order under a larger Indefinite Delivery Contract vehicle, utilizes firm fixed pricing and is scheduled for completion by May 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, was selected through open competition with no set-aside designation. The performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.52 to AmerisourceBergen Drug Corp for Emporphed 50 mg/10 mL vials on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 1 mg/ml ampules with a ceiling value of $1,545.95. This firm fixed-price delivery order, which has an ultimate completion date of August 15, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...